A new study sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer.
A multi-institutional, randomized phase III trial of fractionation in locally advanced head and neck cancer demonstrated improved local-regional control and improved overall survival with no increase in late toxicity with hyperfractionated radiation therapy.
In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy were cancer-free 28 months after treatment. Side effects typical of standard radiation were also reduced in some cases.
A team of clinicians proposed a virtual navigation system that would allow patients to follow the same pathway as clinic patients but without the formal clinic setting.
Researchers at New York University College of Dentistry and at University of California San Francisco are investigating a potential association between oral cancers and chronic microbial diseases of the oral cavity.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|